http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101146335-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0275 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61D19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 |
filingDate | 2009-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2012-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2012-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101146335-B1 |
titleOfInvention | A transgenic mouse expressing a reporter protein under the control of an alpha fetal protein enhancer and a promoter, a method for preparing the same, and a method for screening a substance for increasing or decreasing alpha fetal protein expression using the same |
abstract | One or more embodiments relate to a transgenic mouse expressing a reporter protein under the control of an alphafetoprotein enhancer and a promoter, a method for preparing the same, and a method for screening a substance for increasing or decreasing alpha fetal protein expression using the same. Transgenic mice expressing reporter proteins under the control of alpha-fetoprotein enhancers and promoters according to one or more embodiments can be screened for molecular biological studies on the development of liver cancer and screening of liver cancer-producing candidates and candidates that inhibit the proliferation of liver cancer cells. It can be used to study liver cancer treatment. |
priorityDate | 2009-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 348.